Adam Dinerman Email

VP and CMC Head . Aro Biotherapeutics

Current Roles

Employees:
54
Revenue:
$4.2M
About
Unlocking the Potential of Genetic Medicines Based in Philadelphia, Aro Biotherapeutics is a biotechnology company pioneering the development of tissue-targeted genetic medicines with a platform based on a proprietary protein technology called Centyrins. The company is developing a wholly-owned pipeline of Centyrin-based therapeutic candidates and is working with industry partners to leverage Centyrins for tissue-specific targeting of therapeutics for a diverse set of diseases.
Aro Biotherapeutics Address
601 Walnut Street
Philadelphia, PA
United States
Aro Biotherapeutics Email

Past Companies

Aro BiotherapeuticsVice President and CMC Head
Aro BiotherapeuticsExecutive Director and CMC Head
Johnson & JohnsonDirector, CMC Team Leader - Portfolio Management & Technical Integration

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.